Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biologic dose-reduction strategies in rheumatoid arthritis remission
2012-004482-40Phase 4Active
- Sponsor
- FRANCISCO J. BLANCO GARC�A
- Start
- May 2013
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab, adalimumab, etanercept, certolizumab pegol, golimumab in rheumatoid arthritis (RA), sponsored by FRANCISCO J. BLANCO GARC�A. Started May 2013; status: active.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2012-004482-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004482-40.